Literature DB >> 12424488

Bone mineral density in juvenile systemic lupus erythematosus.

T C M Castro1, M T Terreri, V L Szejnfeld, C H M Castro, M Fisberg, M Gabay, M O E Hilário.   

Abstract

We evaluated spine bone mineral density (BMD) in Brazilian children with juvenile systemic lupus erythematosus (JSLE) in order to detect potential predictors of reduction in bone mass. A cross-sectional study of BMD at the lumbar spine level (L2-L4) was conducted on 16 female JSLE patients aged 6-17 years. Thirty-two age-matched healthy girls were used as control. BMD at the lumbar spine was measured by dual-energy X-ray absorptiometry. Weight, height and pubertal Tanner stage were determined in patients and controls. Disease duration, mean daily steroid doses, mean cumulative steroid doses and JSLE activity measured by the systemic lupus erythematosus disease activity index (SLEDAI) were determined for all JSLE patients based on their medical charts. All parameters were used as potential determinant factors for bone loss. Lumbar BMD tended to be lower in the JSLE patients, however, this difference was not statistically significant (P = 0.10). No significant correlation was observed in JSLE girls between BMD and age, height, Tanner stage, disease duration, corticosteroid use or disease activity. We found a weak correlation between BMD and weight (r = 0.672). In the JSLE group we found no significant parameters to correlate with reduced bone mass. Disease activity and mean cumulative steroid doses were not related to BMD values. We did not observe reduced bone mass in female JSLE.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12424488     DOI: 10.1590/s0100-879x2002001000008

Source DB:  PubMed          Journal:  Braz J Med Biol Res        ISSN: 0100-879X            Impact factor:   2.590


  5 in total

Review 1.  Prevalence and burden of pediatric-onset systemic lupus erythematosus.

Authors:  Sylvia Kamphuis; Earl D Silverman
Journal:  Nat Rev Rheumatol       Date:  2010-08-03       Impact factor: 20.543

2.  Prevalent vertebral fractures among children initiating glucocorticoid therapy for the treatment of rheumatic disorders.

Authors:  A M Huber; I Gaboury; D A Cabral; B Lang; A Ni; D Stephure; S Taback; P Dent; J Ellsworth; C LeBlanc; C Saint-Cyr; R Scuccimarri; J Hay; B Lentle; M Matzinger; N Shenouda; D Moher; F Rauch; K Siminoski; L M Ward
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-04       Impact factor: 4.794

3.  Bone mineral density reduction in adolescents with systemic erythematosus lupus: association with lack of vitamin D supplementation.

Authors:  M Caetano; M T Terreri; T Ortiz; M Pinheiro; F Souza; R Sarni
Journal:  Clin Rheumatol       Date:  2015-07-31       Impact factor: 2.980

Review 4.  Pediatric DXA: clinical applications.

Authors:  Larry A Binkovitz; Paul Sparke; Maria J Henwood
Journal:  Pediatr Radiol       Date:  2007-04-13

5.  IS THERE AN ASSOCIATION BETWEEN GLUCOCORTICOID USE AND FRACTURES? A COMPARATIVE STUDY IN A TRAUMA HOSPITAL.

Authors:  Emanuel Sávio Cavalcanti Sarinho; Verônica Maria Pinho Pessôa Melo; Marcelo Tavares Viana; Marina Maria Pessôa Melo
Journal:  Rev Paul Pediatr       Date:  2018-07-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.